| scholarly article | Q13442814 |
| P356 | DOI | 10.2217/FMB.12.31 |
| P698 | PubMed publication ID | 22568712 |
| P50 | author | Thomas J Walsh | Q108430075 |
| P2093 | author name string | Scott R Penzak | |
| Brad Moriyama | |||
| Stacey A Henning | |||
| P2860 | cites work | Escape of Candida from caspofungin inhibition at concentrations above the MIC (paradoxical effect) accomplished by increased cell wall chitin; evidence for beta-1,6-glucan synthesis inhibition by caspofungin | Q24674839 |
| Echinocandin antifungal drugs | Q29398696 | ||
| Postantifungal effects of echinocandin, azole, and polyene antifungal agents against Candida albicans and Cryptococcus neoformans | Q33979304 | ||
| Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis | Q33981387 | ||
| In vitro activity of micafungin (FK-463) against Candida spp.: microdilution, time-kill, and postantifungal-effect studies | Q34253266 | ||
| Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. | Q34936576 | ||
| Paradoxical growth effect of caspofungin observed on biofilms and planktonic cells of five different Candida species | Q36094887 | ||
| The echinocandins | Q36742397 | ||
| Anidulafungin is fungicidal and exerts a variety of postantifungal effects against Candida albicans, C. glabrata, C. parapsilosis, and C. krusei isolates | Q37274747 | ||
| In vitro pharmacodynamic characteristics of amphotericin B, caspofungin, fluconazole, and voriconazole against bloodstream isolates of infrequent Candida species from patients with hematologic malignancies | Q37598686 | ||
| In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies. | Q39657947 | ||
| Paradoxical effect of caspofungin: reduced activity against Candida albicans at high drug concentrations | Q39954432 | ||
| Attenuation of the activity of caspofungin at high concentrations against candida albicans: possible role of cell wall integrity and calcineurin pathways. | Q40668367 | ||
| Characterizing the effects of caspofungin on Candida albicans, Candida parapsilosis, and Candida glabrata isolates by simultaneous time-kill and postantifungal-effect experiments | Q41473569 | ||
| Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms | Q41912237 | ||
| Paradoxical effect of caspofungin against Candida bloodstream isolates is mediated by multiple pathways but eliminated in human serum | Q41963359 | ||
| Assessment of the paradoxical effect of caspofungin in therapy of candidiasis | Q42090519 | ||
| Changes in cell wall synthesis and ultrastructure during paradoxical growth effect of caspofungin on four different Candida species. | Q42111171 | ||
| Five-minute exposure to caspofungin results in prolonged postantifungal effects and eliminates the paradoxical growth of Candida albicans | Q42111926 | ||
| Paradoxical effect of Echinocandins across Candida species in vitro: evidence for echinocandin-specific and candida species-related differences | Q42747700 | ||
| In vivo studies with a Candida tropicalis isolate exhibiting paradoxical growth in vitro in the presence of high concentration of caspofungin | Q43076592 | ||
| A comparative study of the post-antifungal effect (PAFE) of amphotericin B, triazoles and echinocandins on Aspergillus fumigatus and Candida albicans | Q44733004 | ||
| Studies of the paradoxical effect of caspofungin at high drug concentrations | Q46377599 | ||
| P433 | issue | 5 | |
| P1104 | number of pages | 5 | |
| P304 | page(s) | 565-569 | |
| P577 | publication date | 2012-05-01 | |
| P1433 | published in | Future Microbiology | Q15759961 |
| P1476 | title | The postantifungal and paradoxical effects of echinocandins against Candida spp. | |
| P478 | volume | 7 |
| Q46639635 | Development of New Strategies for Echinocandins: Progress in Translational Research. |
| Q39458862 | Echinocandins in antifungal pharmacotherapy. |
| Q55511181 | Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms. |
| Q38193337 | Pharmacokinetics and pharmacodynamics of antifungals in children and their clinical implications. |
| Q35689690 | Postantifungal Effect of Micafungin against the Species Complexes of Candida albicans and Candida parapsilosis |
| Q49679966 | Recent Insights into the Paradoxical Effect of Echinocandins |
| Q37026730 | Species-specific and drug-specific differences in susceptibility of Candida biofilms to echinocandins: characterization of less common bloodstream isolates |
| Q40173835 | The Aspergillus fumigatus CrzA Transcription Factor Activates Chitin Synthase Gene Expression during the Caspofungin Paradoxical Effect. |
Search more.